US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Ultragenyx Pharmaceutical Inc (RARE)
Ultragenyx Pharmaceutical Inc (RARE) ニュース

RARE

Ultragenyx Pharmaceutical (RARE)

Ultragenyx Pharmaceutical Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RARE

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/26	21 : 00	GlobeNewswire Inc.	Ultragenyx Announces Upcoming Setrusumab (UX143) Presentations at the ASBMR 2024 Annual Meeting	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/09/19	06 : 00	GlobeNewswire Inc.	Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/09/19	02 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/09/06	00 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/08/30	05 : 30	GlobeNewswire Inc.	Ultragenyx to Participate in Investor Conferences in September	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/08/23	20 : 00	Business Wire	Tactical Resources, a Growing North American Rare Earth Elements Company, to List on NASDAQ	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/08/22	05 : 30	GlobeNewswire Inc.	Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/08/02	05 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/08/02	05 : 05	GlobeNewswire Inc.	Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/07/26	05 : 05	GlobeNewswire Inc.	Ultragenyx to Host Conference Call for Second Quarter 2024 Financial Results and Corporate Update	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/07/24	21 : 00	GlobeNewswire Inc.	Ultragenyx to Present GTX-102 Angelman Syndrome Program Update at the ASF Family Conference and Research Symposium	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/07/20	05 : 05	GlobeNewswire Inc.	Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/07/18	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/07/18	05 : 05	GlobeNewswire Inc.	Ultragenyx Announces Successful End-of-Phase 2 Meeting with FDA for GTX-102 Angelman Syndrome Program	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/07/13	05 : 04	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/21	05 : 30	GlobeNewswire Inc.	Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/21	03 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/21	03 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/21	03 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/17	19 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/15	06 : 11	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/14	09 : 49	GlobeNewswire Inc.	Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/13	08 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/13	06 : 20	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/13	06 : 10	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/13	05 : 05	GlobeNewswire Inc.	Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/13	05 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/13	05 : 00	GlobeNewswire Inc.	Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/12	06 : 47	GlobeNewswire Inc.	Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc
2024/06/11	08 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RARE	Ultragenyx Pharmaceutical Inc

Showing the most relevant articles for your search:NASDAQ:RARE

1 2 3 4 5 6 7 8 9 10 次へ >>

Horizons Enhanced Income...

Euronet Worldwide

Tamarack Valley Energy

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約